Corporate Banner
Satellite Banner
Technology Networks Header
Monday, October 20, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

MabVax Enters Agreements with MSKCC and Juno
Friday, September 12, 2014
Agreement for the development of novel therapeutic products using antibody targeting sequences.

Blocking One Receptor on Cells Could Halt Rheumatoid Arthritis
Friday, September 12, 2014
Researchers uncovered multiple pathological processes driven by the activation of the receptor.

New Defence Mechanism Against Viruses Discovered
Friday, September 12, 2014
Mechanism may represent one of the oldest defence mechanisms against viruses in evolutionary history.

Seattle Genetics and Genmab Collaborate
Friday, September 12, 2014
Collaboration combines Genmab’s proprietary antibodies and Seattle Genetics’ ADC technology. The new ADC program will target AXL expressed on multiple tumor types.

Center for Advanced Cellular Therapeutics to Rise on Penn Medicine Campus
Friday, September 12, 2014
New facility poised to accelerate the research and development of personalized cellular cancer therapies.

Seattle Genetics and Genmab Enter into New ADC Collaboration
Thursday, September 11, 2014
New ADC program will target AXL expressed on multiple tumor types.

Allergopharma and S-TARget Conclude Licensing Agreement
Wednesday, September 10, 2014
Objective is new generation of therapeutics for allergy treatment.

Abcam Announces Appointment of New CEO and Board Changes
Tuesday, September 09, 2014
The previous long-serving Chief Executive and co-Founder of Abcam, Jonathan Milner, will continue to play an active role in the Company as Deputy Chairman.

Rockland Awarded SBIR Funding
Tuesday, September 09, 2014
Company awarded grant to develop antibody-based point of care device for the diagnosis of sickle cell disease.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 1212
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv